Amidst the artificial intelligence (AI) boom, Microsoft Corporation (MSFT), a global tech giant and a major player in the AI market, has seen relatively moderate stock performance. Over the past 12 months, while numerous AI-themed stocks have recorded double-digit percentage gains, Microsoft’s stock price has risen only about 6%. However, analysis suggests this does not prevent it from being one of the safest AI investment choices for 2026 and beyond.
Microsoft’s strength in the AI field lies in its balanced layout. Over the past decade, the company has successfully reduced its reliance on traditional desktop software by aggressively expanding its cloud and mobile ecosystems. Its Azure cloud infrastructure platform has grown to become the world’s second-largest, trailing only Amazon’s (AMZN) AWS. Simultaneously, Microsoft has fully transitioned its productivity software to cloud services and mobile applications, laying a solid foundation for launching AI services, enhancing cybersecurity capabilities, and empowering developer tools. Furthermore, the expansion of its Xbox gaming business and first-party hardware devices has attracted a broader user base. This strategy of scale and diversification allows Microsoft to benefit evenly from multiple growth areas, including cloud computing, AI, consumer electronics, and gaming.
Looking ahead, analytical firms project that from fiscal year 2025 to fiscal year 2028, Microsoft’s revenue and earnings per share will achieve compound annual growth rates of 16% and 18%, respectively. This growth momentum primarily stems from the deep integration of its Copilot assistant across various services, the launch of advanced AI agents capable of replacing human labor, and the commercialization of these AI features. To this end, Microsoft plans to invest tens of billions of dollars annually for the next several years to upgrade its AI infrastructure, including building new data centers and developing its own AI chips. While these substantial expenditures have raised concerns among some investors, the stable cash flow generated by Microsoft’s high-margin software and cloud businesses is sufficient to easily offset these cost pressures.
Currently, Microsoft’s stock price hovers around $405, with a forward price-to-earnings ratio of 21 times based on expected earnings for the next fiscal year, representing a reasonable valuation. Although it may not grow as explosively as companies like Nvidia (NVDA), Microsoft offers investors a solid avenue to participate in the growth of the AI market.
Microsoft is extending its AI capabilities into the consumer health sector with the launch of a new service called Copilot Health. This service can integrate data from multiple sources, including wearable devices, health records, and laboratory results, to provide users with “health intelligence.” Microsoft envisions this as paving the way toward “medical superintelligence”—a health AI that combines the breadth of a general practitioner’s knowledge with the depth of a specialist’s expertise.
Copilot Health will be rolled out in phases, initially launching in the United States for users aged 18 and older in English. It can access data from over 50 types of wearable devices, including Fitbit, Oura, and Apple Health, and integrate health records from more than 50,000 healthcare institutions across the U.S. via the HealthEx platform, including visit summaries, medication lists, and test results. Microsoft emphasizes that Copilot Health’s data is isolated from regular Copilot functionalities and will not be used to train AI models. It is equipped with strict privacy and security controls, including encryption, allowing users to manage and delete their data independently.
As Apple (AAPL), OpenAI, Amazon, and other companies have successively launched or updated their health AI services, Microsoft’s entry further intensifies competition in this field.
